Previous close | 34.87 |
Open | N/A |
Bid | 33.65 |
Ask | 35.55 |
Strike | 42.50 |
Expiry date | 2025-01-17 |
Day's range | 34.87 - 34.87 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.